Upgrades:
Merck (MRK) upgraded to Outperform from Neutral at Credit Suisse; target $73
Downgrades:
JPMorgan Chase (JPM) downgraded to Neutral from Buy at Citigroup
Other:
By clicking "OK" you are providing your consent to our use of cookies. For more information, please read our Privacy Policy